China Bio-pharmaceutical Summit 2009 to be Organized by CBI China
* Reuters is not responsible for the content in this press release.
-- Shanghai, China, Dec. 10th-11th SHANGHAI--(Business Wire)-- Biotechnology is an emerging industry to which many countries are attaching great importance. China is determined to grasp the great opportunities brought by the biotechnology revolution. Biotech industry will become a pillar of China`s hi-tech sector, in which bio-pharmaceutical is playing a leading role. How do pharmaceutical companies understand medicine pricing administration? How to maximize the achievement after the success of R&D? How do we select the products with high potentials while popular products are playing a bigger role? In the China Bio-pharmaceutical Summit 2009 (Dec. 10th -11th, Shanghai China), the above mentioned questions will be answered thoroughly. This event features the theme of "boosting industry integration and innovation through in-depth interpretation of policies and market landscape; focusing on industry milestones of 2009", so as to enhance the high-level exchange between bio-pharmaceutical enterprises, research institutes, contractors, relevant service providers and investment institutions, etc. The Bacterin Day on Dec. 11thwill highlight topics on bacterin technologies, vaccine transportation and testing, advice on legal and investment issues, etc. This session will help the delegates better understand the vaccine market. Confirmed attendees include (without limitation): AstraZeneca Pharmaceutical Co., Ltd. Aisa, R&D Director Livzon Pharmaceutical Group Inc, R&D Manager Beijing kendlewits Pharmaceutical, Marketing Manager Medical Information Consulting Co., Ltd., Marketing Director Keyuan Xinhai Pharmaceutical Management Co., Ltd., Project Manager Merck Sharp & Dohme (China) Co., Ltd., Director Ministry of Health of the People's Republic, Director China Bio-Technology Group Headquarters, Vice President Otsuka (China) Investment Co., Ltd., Investment Manager Chinese Center for Disease Control and Prevention, Director Biomedical Development Co., Ltd., CRO Project Manager Medicine & human Body Research of Zhouyi Theory, President GlaxoSmithKline Biological Products Co., Ltd., General Manager … For more information, please visit: http://events.cbichina.com/con/bio09/index.html CBI (Shanghai) Co., Ltd. Ms. Zoe Zhong, 86-21-51550928 zoezhong@cbichina.com Copyright Business Wire 2009
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.
Follow Reuters